Ken Jarvis

1.2k total citations
7 papers, 175 citations indexed

About

Ken Jarvis is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Ken Jarvis has authored 7 papers receiving a total of 175 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Oncology. Recurrent topics in Ken Jarvis's work include Cancer therapeutics and mechanisms (3 papers), DNA Repair Mechanisms (2 papers) and PARP inhibition in cancer therapy (2 papers). Ken Jarvis is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), DNA Repair Mechanisms (2 papers) and PARP inhibition in cancer therapy (2 papers). Ken Jarvis collaborates with scholars based in United States and United Kingdom. Ken Jarvis's co-authors include Gui‐Dong Zhu, Vincent L. Giranda, Eric F. Johnson, Vered Klinghofer, Xuesong Liu, Yan Shi, Saul H. Rosenberg, Cherrie K. Donawho, David J. Frost and Thomas D. Penning and has published in prestigious journals such as Journal of Nutrition, Antimicrobial Agents and Chemotherapy and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Ken Jarvis

7 papers receiving 168 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ken Jarvis United States	5	90	74	66	14	13	7	175
Santosh Kumar Chaudhary United States	9	278 3.1×	49 0.7×	85 1.3×	9 0.6×	35 2.7×	22	347
Jun Hee Hong Australia	8	104 1.2×	88 1.2×	40 0.6×	2 0.1×	21 1.6×	15	202
Jonathan Langille United States	5	81 0.9×	134 1.8×	74 1.1×	42 3.0×	9 0.7×	9	257
Mandana Karimi Iran	6	66 0.7×	205 2.8×	30 0.5×	103 7.4×	11 0.8×	14	321
Brian Jones United States	10	84 0.9×	107 1.4×	22 0.3×	38 2.7×	16 1.2×	15	264
Khanh Tran United States	3	65 0.7×	39 0.5×	42 0.6×	6 0.4×	21 1.6×	6	110
Guqin Shi United States	6	148 1.6×	53 0.7×	19 0.3×	30 2.1×	23 1.8×	11	229
Marie-Laure Nicolau-Travers France	9	89 1.0×	15 0.2×	36 0.5×	21 1.5×	6 0.5×	11	185
Cong-Dat Pham United States	8	94 1.0×	79 1.1×	24 0.4×	8 0.6×	21 1.6×	16	256
Jordan D. Carelli United States	5	138 1.5×	52 0.7×	39 0.6×	3 0.2×	5 0.4×	5	168

Countries citing papers authored by Ken Jarvis

Since Specialization

Citations

This map shows the geographic impact of Ken Jarvis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Jarvis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Jarvis more than expected).

Fields of papers citing papers by Ken Jarvis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Jarvis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Jarvis. The network helps show where Ken Jarvis may publish in the future.

Co-authorship network of co-authors of Ken Jarvis

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Jarvis. A scholar is included among the top collaborators of Ken Jarvis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Jarvis. Ken Jarvis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Liu, Xuesong, Yan Shi, Ran Guan, et al.. (2008). Potentiation of Temozolomide Cytotoxicity by Poly(ADP)Ribose Polymerase Inhibitor ABT-888 Requires a Conversion of Single-Stranded DNA Damages to Double-Stranded DNA Breaks. Molecular Cancer Research. 6(10). 1621–1629. 61 indexed citations

2.

Zhu, Gui‐Dong, Viraj B. Gandhi, Jianchun Gong, et al.. (2008). Synthesis and SAR of novel, potent and orally bioavailable benzimidazole inhibitors of poly(ADP-ribose) polymerase (PARP) with a quaternary methylene-amino substituent. Bioorganic & Medicinal Chemistry Letters. 18(14). 3955–3958. 42 indexed citations

3.

Zhu, Gui‐Dong, Viraj B. Gandhi, Jianchun Gong, et al.. (2006). Discovery and SAR of oxindole–pyridine-based protein kinase B/Akt inhibitors for treating cancers. Bioorganic & Medicinal Chemistry Letters. 16(13). 3424–3429. 42 indexed citations

4.

Jarvis, Ken, et al.. (2005). Cases in Hospitality and Tourism Management. 1 indexed citations

5.

Drabu, Y., et al.. (2004). Strongyloidiasis: a mistaken diagnosis and a fatal outcome in a patient with diarrhoea. Transactions of the Royal Society of Tropical Medicine and Hygiene. 99(3). 215–217. 10 indexed citations

6.

Ewing, Patty J., et al.. (1998). In Vivo Efficacy of ABT-255 against Drug-Sensitive and -Resistant Mycobacterium tuberculosis Strains. Antimicrobial Agents and Chemotherapy. 42(10). 2674–2677. 16 indexed citations

7.

Alder, Jeffrey, et al.. (1994). Enteral Formula Composition Does Not Affect Response to Lethal Infectious Challenge in Mice. Journal of Nutrition. 124(11). 2156–2162. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact